AC
BIOR

Armistice Capital’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Armistice Capital’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-33,469
Closed -$1.1M – 273
2022
Q4 		$1.1M Buy
+33,469
New +$2.44M 0.02% 127
2021
Q3 		– Sell
-30,389
Closed -$27.1M – 163
2021
Q2 		$27.1M Buy
30,389
+19,899
+190% +$15.2M 0.49% 54
2021
Q1 		$12.5M Buy
+10,490
New +$14.5M 0.29% 70
2020
Q4 		– Sell
-1,600
Closed -$3.61M – 127
2020
Q3 		$3.61M Buy
+1,600
New +$3.62M 0.13% 84

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Armistice Capital's BIOR Position: Q1 2023 in Review

Armistice Capital sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q1 2023, closing a stake of 33,469 shares — an estimated $1.1M sold.

Armistice Capital first reported a position in BIOR in Q3 2020 and held it in 4 quarters. The position peaked at $27.1M in Q2 2021. 30 funds tracked by Wall St. Rank hold BIOR as of Q1 2023.

  • Armistice Capital reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Armistice Capital sold 33,469 Biora Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $1.1M.
  • Armistice Capital first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Armistice Capital's Biora Therapeutics, Inc. Common Stock position peaked at $27.1M in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Armistice Capital's 13F filing for Q1 2023, filed 15 May 2023.